897 related articles for article (PubMed ID: 11727737)
1. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
[TBL] [Abstract][Full Text] [Related]
2. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
[TBL] [Abstract][Full Text] [Related]
3. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization.
Gehlbach P; Demetriades AM; Yamamoto S; Deering T; Duh EJ; Yang HS; Cingolani C; Lai H; Wei L; Campochiaro PA
Gene Ther; 2003 Apr; 10(8):637-46. PubMed ID: 12692592
[TBL] [Abstract][Full Text] [Related]
4. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.
Mori K; Duh E; Gehlbach P; Ando A; Takahashi K; Pearlman J; Mori K; Yang HS; Zack DJ; Ettyreddy D; Brough DE; Wei LL; Campochiaro PA
J Cell Physiol; 2001 Aug; 188(2):253-63. PubMed ID: 11424092
[TBL] [Abstract][Full Text] [Related]
5. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.
Rosenfeld PJ; Schwartz SD; Blumenkranz MS; Miller JW; Haller JA; Reimann JD; Greene WL; Shams N
Ophthalmology; 2005 Jun; 112(6):1048-53. PubMed ID: 15885778
[TBL] [Abstract][Full Text] [Related]
6. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
[TBL] [Abstract][Full Text] [Related]
7. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial.
Campochiaro PA; Nguyen QD; Shah SM; Klein ML; Holz E; Frank RN; Saperstein DA; Gupta A; Stout JT; Macko J; DiBartolomeo R; Wei LL
Hum Gene Ther; 2006 Feb; 17(2):167-76. PubMed ID: 16454650
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization.
Zhou XY; Liao Q; Pu YM; Tang YQ; Gong X; Li J; Xu Y; Wang ZG
Chin Med J (Engl); 2009 Nov; 122(22):2711-7. PubMed ID: 19951601
[TBL] [Abstract][Full Text] [Related]
10. [Progress on study of treatment of age-related macular degeneration by pigment epithelial-derived factor].
Hou HY; Wang YS
Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):181-5. PubMed ID: 20388353
[TBL] [Abstract][Full Text] [Related]
11. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Rosenfeld PJ; Heier JS; Hantsbarger G; Shams N
Ophthalmology; 2006 Apr; 113(4):623.e1. PubMed ID: 16581423
[TBL] [Abstract][Full Text] [Related]
12. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
13. Simian lentiviral vector-mediated retinal gene transfer of pigment epithelium-derived factor protects retinal degeneration and electrical defect in Royal College of Surgeons rats.
Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Sakamoto T; Tabata T; Ueda Y; Hasegawa M; Tobimatsu S; Ishibashi T; Sueishi K
Gene Ther; 2003 Aug; 10(17):1503-11. PubMed ID: 12900766
[TBL] [Abstract][Full Text] [Related]
14. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
Verma L; Das T; Binder S; Heriot WJ; Kirchhof B; Venkatesh P; Krebs I; Stolba U; Jahn C; Feichtinger H; Kellner L; Krugluger H; Pawelka I; Frohner U; Kruger A; Li W; Tewari HK
Indian J Ophthalmol; 2000 Dec; 48(4):263-78. PubMed ID: 11340884
[TBL] [Abstract][Full Text] [Related]
15. Met72Thr polymorphism of pigment epithelium-derived factor gene and susceptibility to age-related macular degeneration.
Yamagishi S; Nakamura K; Inoue H; Takeuchi M
Med Hypotheses; 2005; 64(6):1202-4. PubMed ID: 15823717
[TBL] [Abstract][Full Text] [Related]
16. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
Ogata N; Wada M; Otsuji T; Jo N; Tombran-Tink J; Matsumura M
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1168-75. PubMed ID: 11923262
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF.
Ohno-Matsui K; Morita I; Tombran-Tink J; Mrazek D; Onodera M; Uetama T; Hayano M; Murota SI; Mochizuki M
J Cell Physiol; 2001 Dec; 189(3):323-33. PubMed ID: 11748590
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
Cashman SM; Bowman L; Christofferson J; Kumar-Singh R
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
[TBL] [Abstract][Full Text] [Related]
19. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
Bandello F; Lafuma A; Berdeaux G
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
[TBL] [Abstract][Full Text] [Related]
20. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
